SAGE Therapeutics (AgeTech UK) NeuroTech
Brain focused: neurological and neuropsychiatric disorders, various neurodegenerative disorders, and depression.
Investment Stage:
N/A
Funding Status:
N/A
Headquarters:
United Kingdom
Industry:
UK AgeTech 2020
Number Of Exists:
N/A
Investor Type:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Founded Date:
N/A

